<html>
<head>
    <meta http-equiv="content-type" content="text/html; charset=utf-8" />
    <meta name="description" content="" />
    <meta name="keywords" content="" />
    <!--[if lte IE 8]><script src="css/ie/html5shiv.js"></script><![endif]-->
    <script src="/js/jquery.min.js"></script>
    <script src="/js/jquery.dropotron.min.js"></script>
    <script src="/js/skel.min.js"></script>
    <script src="/js/skel-layers.min.js"></script>
    <script src="/js/init.js"></script>
    <link rel="stylesheet" href="/css/pygment.css" />
    <noscript>
        <link rel="stylesheet" href="/css/skel.css" />
        <link rel="stylesheet" href="/css/style.css" />
        <link rel="stylesheet" href="/css/style-noscript.css" />
    </noscript>
    <script src="//cdnjs.cloudflare.com/ajax/libs/modernizr/2.6.2/modernizr.min.js"></script>
    <!-- <link href="//netdna.bootstrapcdn.com/font-awesome/4.1.0/css/font-awesome.min.css" rel="stylesheet"> -->
    <link rel="stylesheet" href="//cdn.materialdesignicons.com/1.3.41/css/materialdesignicons.min.css">
    <link  href="http://fonts.googleapis.com/css?family=Anonymous+Pro:regular,italic,bold,bolditalic" rel="stylesheet" type="text/css" >
    <!--[if lte IE 8]><link rel="stylesheet" href="/css/ie/v8.css" /><![endif]-->
    <!--[if lte IE 9]><link rel="stylesheet" href="/css/ie/v9.css" /><![endif]-->
    <style>
    body, #skel-layers-wrapper {
    background: #CFF4EF;
}
    </style>

    <title>TomasÂ Bos | Yeo Lab Yeo Lab</title>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width">
</head>

<body class=" loading">



    <!-- Header -->
    <header id="header" >
        <h1 class="logo">
            <a href="..">Yeo Lab</a>
        </h1>
        <nav id="nav">
            <ul>
                <!-- <li class="current"><a href="index.html">Welcome</a></li> -->
                    <li><a href="/research/">Research</a></li>
                    <li><a href="/papers/">Papers</a></li>
                    <li><a href="/gallery/">Photos</a></li>
                    <li><a href="/funding/">Funding</a></li>
                    <li><a href="/software/">Software</a></li>
                <li><a href="/contact" class="button special">Contact</a></li>
            </ul>
        </nav>
    </header>

<style>
.image:before{
  background-image: None;
}
img.clown {
  height: 100%;
  /*Border-radius 50% makes it a circle*/
  border-radius: 50%;
  margin-top: -49px;
}
</style>
<!-- Main -->
<article id="main">

  <header class="special container">
    <span class="icon"><img src="/images/people/tomas_bos.png" class="clown"></span>
    <h2>Tomas&nbsp;Bos</h2>
    <!-- add page sub title here -->
    <p>Post-Doctoral Fellow

      <!-- If there's a position suffix
      (e.g. Bioinformatics Analyst "I, (Ph.D.))"", add it -->

      <!-- If they are alumni, specify -->
<br>

      <!-- Add program/department affiliation, if applicable -->
      Cellular and Molecular Medicine<br>

    <!-- Add their fellowship, if applicable -->
    Tbos@ucsd.edu</p>
  </header>

  <!-- One -->
    <section class="wrapper style4 container">

      <!-- Content -->
        <div class="content">
          <section>
            <p><h2>Degrees</h2>
<p>PhD in Medical Sciences, Vrije Universiteit Brussel, 2010<br>
<span class="caps">M.S.</span> in Molecular Biology and Biotechnology, Vrije Universiteit Brussel, 2004<br>
<span class="caps">M.S.</span> in Biotechnical Engineering, De Nayer Instituut, 2003<br>
B.S Pharmaceutical and Biological Techniques, Erasmushogeschool Brussel, 2001<br></p>
<h2>Summary</h2>
<p>Tomas Bos received his PhD in Medical Sciences from the Vrije Universiteit Brussel, Belgium in 2010. Dr. Bos investigated during his PhD novel ways to deliver lentiviral vectors more efficiently to cancer cells. Another focus during his PhD was the explodingfield of epigenetics. He identified novel epigenetic layers in the regulation of the pro-apoptotic Bim protein in Multiple Myeloma. More specific, he showed that the <span class="caps">IGF1</span> growth factor is directly involved in modifying the epigenetic signature of both the Bim and the FoxO3A promoter. His wide interest in science resulted in publications in very diverse fields ranging from diabetes to in vivo small animal imaging and in the Emmanuel Vander Schueren Award. Before joining the Yeo lab, he stayed a fewmonths at the Salk Institute in the department of Regulatory Biology to study the role of <span class="caps">CTCF</span> in breast cancer. Dr. Bos is now studying the role of <span class="caps">RNA</span>-binding proteins (RBPs) in alternative splicing of pre-mRNA. Other projects he is involved in are the use of genomic engineering tools (<span class="caps">TALEN</span> and <span class="caps">CRIPR</span>/<span class="caps">CAS</span>) to engineer recombinant cell lines, the <span class="caps">ENCODE</span> project studying the sequence specificity of RBPs in <span class="caps">RNA</span> and the family of <span class="caps">ADAR</span> proteins Dr. Bos is funded by the Belgian American Education Foundation (<span class="caps">BAEF</span>) and is a Hoover Foundation Brussels&nbsp;Fellow.</p>
<h2>Publications</h2>
<p>Coming&nbsp;Soon!</p></p>
          </section>
        </div>

    </section>

  </article>


    <!-- <!-- Footer -->
<footer id="footer">

    <ul class="icons">
        <li>
          <a href="http://github.com/yeolab" class="mdi mdi-github-circle"><span class="label"></span></a>
        </li>
        <li>
          <a href="http://twitter.com/yeo_lab" class="mdi mdi-twitter-circle"><span class="label"></span></a>
        </li>
    </ul>

    <span class="copyright">&copy; Yeo Lab. All rights reserved. Design: <a href="http://html5up.net">HTML5 UP</a>.</span>

</footer> -->

</body>
</html>